MUKKA NSE filing

Mukka Proteins Executes LLP Agreement for MPL HRC Ecosolutions LLP

The RealCase readLow impact Neutral

Mukka Proteins Limited executed an LLP agreement with Msjathin Infra Private Limited and Mr. Hardik Gowda on January 22, 2026, for the incorporation of MPL HRC Ecosolutions LLP. The LLP will focus on leachate, water, and bio-waste treatment with an initial capital of ₹5 Lakhs.

Why it matters

The execution of an LLP agreement for a new business venture with an initial capital of ₹5 Lakhs is a routine operational step. The immediate financial impact on Mukka Proteins Limited is likely to be minimal, hence classified as low.

The market read

The announcement details the execution of an LLP agreement for a new business venture. While it outlines the purpose and initial capital, it does not contain specific financial projections or immediate impacts that would strongly suggest a positive or negative sentiment.

Mukka Proteins Limited has executed a Limited Liability Partnership (LLP) Agreement with Msjathin Infra Private Limited and Mr. Hardik Gowda on January 22, 2026. This agreement is in connection with the incorporation of MPL HRC Ecosolutions LLP.

The purpose of this LLP is to define the terms of business, operation, and management of the entity. The initial capital contribution to the LLP will be ₹5,00,000 (Rupees Five Lakhs Only). The business of MPL HRC Ecosolutions LLP will focus on the treatment and disposal of legacy leachate, as well as the treatment of water and bio-waste, and related matters.

Mukka Proteins Limited has nominated Mr. Kalandan Mohamed Haris, Managing Director & CEO, to act as the Designated Partner in the LLP on its behalf. Msjathin Infra Private Limited and Mr. Hardik Gowda are not related to the promoter, promoter group, or group companies of Mukka Proteins Limited, and the transaction does not fall within related party transactions.

Filing to action

What to do with a filing like this

Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under strategic partnerships. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.

View original filing